This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 Feb;24(2):366-7.

doi: 10.1097/00003246-199602000-00036.

Doxacurium vs. Pancuronium

G S Kantor, W D Hoffman, M J Popovich

PMID: 8605819
DOI: 10.1097/00003246-199602000-00036

Comment

Doxacurium vs. Pancuronium

G S Kantor et al. Crit Care Med. 1996 Feb.

. 1996 Feb;24(2):366-7.

doi: 10.1097/00003246-199602000-00036.

Authors

G S Kantor, W D Hoffman, M J Popovich

PMID: 8605819
DOI: 10.1097/00003246-199602000-00036

No abstract available

PubMed Disclaimer

Comment on

Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
Murray MJ, Coursin DB, Scuderi PE, Kamath G, Prough DS, Howard DM, Abou-Donia MA. Murray MJ, et al. Crit Care Med. 1995 Mar;23(3):450-8. doi: 10.1097/00003246-199503000-00007. Crit Care Med. 1995. PMID: 7874894 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer